12 Health Care Stocks Moving In Tuesday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Tuesday's after-market session, several healthcare stocks experienced notable movements. Redhill Biopharma (RDHL) saw an 11.1% increase, while Intelligent Bio Solutions (INBS) dropped by 5.1%. Other gainers included MyMD Pharmaceuticals (MYMD), Ensysce Biosciences (ENSC), Moleculin Biotech (MBRX), Connect Biopharma Hldgs (CNTB), and AIM ImmunoTech (AIM). Losers comprised Humacyte (HUMA), Senti Biosciences (SNTI), Cue Health (HLTH), Aileron Therapeutics (ALRN), and Silk Road Medical (SILK). Market capitalizations were also highlighted, indicating the size of each company.
January 23, 2024 | 9:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Aileron Therapeutics' stock decreased by 4.26% to $4.5, with a market cap of $21.9 million.
ALRN's stock price drop may continue in the short term if the negative sentiment persists among investors.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 80
NEGATIVE IMPACT
Cue Health's stock decreased by 4.53% to $0.21, with a market cap of $32.6 million.
The negative movement in HLTH's stock price could indicate bearish sentiment, potentially affecting the stock negatively in the short term.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 80
NEGATIVE IMPACT
Humacyte's shares fell 4.82% to $2.77, with a market cap of $286.9 million.
The decline in HUMA's stock price could reflect negative sentiment, possibly leading to a downward trend in the short term.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 80
NEGATIVE IMPACT
Intelligent Bio Solutions' stock decreased by 5.1% to $0.29, with a market cap of $2.5 million.
The after-market decline for INBS may concern investors and could lead to a negative short-term impact on the stock price.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
NEGATIVE IMPACT
Silk Road Medical's stock fell 3.91% to $14.26, with a market cap of $555.3 million.
The decline in SILK's stock price could suggest a negative outlook, potentially leading to further short-term depreciation.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 80
NEGATIVE IMPACT
Senti Biosciences' stock fell 4.81% to $0.42, with a market cap of $18.7 million.
SNTI's after-market drop may lead to further short-term declines as investors react to the negative price movement.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 80
POSITIVE IMPACT
AIM ImmunoTech's shares moved upwards by 4.65% to $0.45, with a market cap of $21.9 million.
AIM's stock price gain could suggest investor confidence, potentially leading to further short-term increases.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 80
POSITIVE IMPACT
Connect Biopharma Hldgs' shares moved upwards by 4.83% to $1.3, with a market cap of $71.5 million.
The increase in CNTB's stock price may continue in the short term, driven by positive after-market trading momentum.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 80
POSITIVE IMPACT
Ensysce Biosciences' shares increased by 7.29% to $1.47, with a market cap of $4.6 million.
The rise in ENSC's stock price suggests positive sentiment that could lead to further short-term appreciation.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 80
POSITIVE IMPACT
Moleculin Biotech's shares increased by 4.99% to $0.48, with a market cap of $16.0 million.
MBRX's after-market gain could indicate a bullish trend, potentially leading to a positive short-term impact on the stock.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 80
POSITIVE IMPACT
MyMD Pharmaceuticals' stock rose 8.14% to $0.2, with a market cap of $9.9 million.
The positive movement in MYMD's stock price could attract short-term investor interest, potentially leading to further gains.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 80
POSITIVE IMPACT
Redhill Biopharma's stock rose 11.1% to $0.99, with a market cap of $19.4 million.
The significant after-market gain for RDHL could lead to increased investor interest and a potential continuation of the upward trend in the short term.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90